• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Macrophage Tropism in Pathogenic HIV-1 and SIV Infections.致病性 HIV-1 和 SIV 感染中的巨噬细胞嗜性。
Viruses. 2020 Sep 25;12(10):1077. doi: 10.3390/v12101077.
2
CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.CXCR6介导的猴免疫缺陷病毒SIVagmSab进入非洲绿猴淋巴细胞表明非CCR5途径在自然宿主感染中广泛使用。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01626-16. Print 2017 Feb 15.
3
The SIV Envelope Glycoprotein, Viral Tropism, and Pathogenesis: Novel Insights from Nonhuman Primate Models of AIDS.猴免疫缺陷病毒包膜糖蛋白、病毒嗜性与发病机制:来自艾滋病非人灵长类动物模型的新见解
Curr HIV Res. 2018;16(1):29-40. doi: 10.2174/1570162X15666171124123116.
4
Reduced Simian Immunodeficiency Virus Replication in Macrophages of Sooty Mangabeys Is Associated with Increased Expression of Host Restriction Factors.黑猩猩猿猴免疫缺陷病毒在乌黑白眉猴巨噬细胞中的复制减少与宿主限制因子表达增加有关。
J Virol. 2015 Oct;89(20):10136-44. doi: 10.1128/JVI.00710-15. Epub 2015 Jul 22.
5
Dualtropic CXCR6/CCR5 Simian Immunodeficiency Virus (SIV) Infection of Sooty Mangabey Primary Lymphocytes: Distinct Coreceptor Use in Natural versus Pathogenic Hosts of SIV.黑猩猩原代淋巴细胞的双嗜性CXCR6/CCR5猿猴免疫缺陷病毒(SIV)感染:SIV天然宿主与致病宿主中不同的共受体使用情况
J Virol. 2015 Sep;89(18):9252-61. doi: 10.1128/JVI.01236-15. Epub 2015 Jun 24.
6
SIV Coreceptor Specificity in Natural and Non-Natural Host Infection: Implications for Cell Targeting and Differential Outcomes from Infection.天然宿主与非天然宿主感染中的猴免疫缺陷病毒共受体特异性:对细胞靶向及感染差异性结果的影响
Curr HIV Res. 2018;16(1):41-51. doi: 10.2174/1570162X15666171124121805.
7
AIDS in african nonhuman primate hosts of SIVs: a new paradigm of SIV infection.非洲感染猴免疫缺陷病毒的非人灵长类动物中的艾滋病:猴免疫缺陷病毒感染的新范例
Curr HIV Res. 2009 Jan;7(1):57-72. doi: 10.2174/157016209787048456.
8
A Quantitative Approach to SIV Functional Latency in Brain Macrophages.一种针对脑巨噬细胞中SIV功能潜伏期的定量方法。
J Neuroimmune Pharmacol. 2019 Mar;14(1):23-32. doi: 10.1007/s11481-018-9803-8. Epub 2018 Aug 30.
9
Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.在猴免疫缺陷病毒包膜糖蛋白 V2 区丧失一个保守的 N-连接糖基化位点可通过增加 CD4 非依赖性细胞间传播增强巨噬细胞嗜性。
J Virol. 2014 May;88(9):5014-28. doi: 10.1128/JVI.02785-13. Epub 2014 Feb 19.
10
Macrophages and HIV-1: An Unhealthy Constellation.巨噬细胞与HIV-1:一个不健康的组合。
Cell Host Microbe. 2016 Mar 9;19(3):304-10. doi: 10.1016/j.chom.2016.02.013.

引用本文的文献

1
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infection.在 HIV-1 感染期间对神经元损伤和神经炎症的原位分析。
Retrovirology. 2024 Jul 1;21(1):11. doi: 10.1186/s12977-024-00644-z.
2
Retinoic acid enhances HIV-1 reverse transcription and transcription in macrophages via mTOR-modulated mechanisms.维甲酸通过 mTOR 调节机制增强巨噬细胞中的 HIV-1 逆转录和转录。
Cell Rep. 2024 Jul 23;43(7):114414. doi: 10.1016/j.celrep.2024.114414. Epub 2024 Jun 28.
3
HIV Latency in Myeloid Cells: Challenges for a Cure.髓系细胞中的HIV潜伏:治愈面临的挑战。
Pathogens. 2022 May 24;11(6):611. doi: 10.3390/pathogens11060611.
4
Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation.HIV-1 Nef 介导的髓样Src 家族激酶 Hck 激活抑制剂阻断巨噬细胞中的 HIV-1 复制并破坏 MHC-I 下调。
ACS Infect Dis. 2022 Jan 14;8(1):91-105. doi: 10.1021/acsinfecdis.1c00288. Epub 2022 Jan 5.

本文引用的文献

1
Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.抗反转录病毒治疗期间循环单核细胞中 HIV 感染的罕见性。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01174-19.
2
Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.在抗逆转录病毒治疗抑制的 SIVmac251 感染的猕猴中,髓样细胞和 CD4 T 细胞构成潜伏储库。
mBio. 2019 Aug 20;10(4):e01659-19. doi: 10.1128/mBio.01659-19.
3
Molecular Mechanism of HIV-1 Entry.HIV-1 进入的分子机制。
Trends Microbiol. 2019 Oct;27(10):878-891. doi: 10.1016/j.tim.2019.06.002. Epub 2019 Jun 28.
4
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy.在接受抑制性抗逆转录病毒治疗的患者的尿道巨噬细胞中存在 HIV-1 储库。
Nat Microbiol. 2019 Apr;4(4):633-644. doi: 10.1038/s41564-018-0335-z. Epub 2019 Feb 4.
5
No recovery of replication-competent HIV-1 from human liver macrophages.未能从人肝巨噬细胞中回收复制型 HIV-1。
J Clin Invest. 2018 Oct 1;128(10):4501-4509. doi: 10.1172/JCI121678. Epub 2018 Sep 10.
6
The evolution of HIV-1 entry phenotypes as a guide to changing target cells.HIV-1 进入表型的演变作为改变靶细胞的指南。
J Leukoc Biol. 2018 Mar;103(3):421-431. doi: 10.1002/JLB.2RI0517-200R. Epub 2018 Feb 1.
7
An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.用于研究与 HIV 相关的神经认知障碍的 SIV/猴模型。
J Neurovirol. 2018 Apr;24(2):204-212. doi: 10.1007/s13365-017-0582-4. Epub 2017 Oct 3.
8
Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.感染猿猴免疫缺陷病毒且接受抗逆转录病毒治疗抑制的猕猴中的脑巨噬细胞:一个功能性潜伏库
mBio. 2017 Aug 15;8(4):e01186-17. doi: 10.1128/mBio.01186-17.
9
A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques.一种靶向中枢神经系统并在恒河猴中诱发神经艾滋病的猴免疫缺陷病毒分子克隆。
PLoS Pathog. 2017 Aug 7;13(8):e1006538. doi: 10.1371/journal.ppat.1006538. eCollection 2017 Aug.
10
The Lifespan and Turnover of Microglia in the Human Brain.人类大脑中小胶质细胞的寿命和更替。
Cell Rep. 2017 Jul 25;20(4):779-784. doi: 10.1016/j.celrep.2017.07.004.

致病性 HIV-1 和 SIV 感染中的巨噬细胞嗜性。

Macrophage Tropism in Pathogenic HIV-1 and SIV Infections.

机构信息

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Viruses. 2020 Sep 25;12(10):1077. doi: 10.3390/v12101077.

DOI:10.3390/v12101077
PMID:32992787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7601331/
Abstract

Most myeloid lineage cells express the receptor and coreceptors that make them susceptible to infection by primate lentiviruses (SIVs and HIVs). However, macrophages are the only myeloid lineage cell commonly infected by SIVs and/or HIVs. The frequency of infected macrophages varies greatly across specific host and virus combinations as well as disease states, with infection rates being greatest in pathogenic SIV infections of non-natural hosts (i.e., Asian nonhuman primates (Asian NHPs)) and late in untreated HIV-1 infection. In contrast, macrophages from natural SIV hosts (i.e., African NHPs) are largely resistant to infection due to entry and/or post-entry restriction mechanisms. These highly variable rates of macrophage infection may stem from differences in the host immune environment, entry and post-entry restriction mechanisms, the ability of a virus to adapt to efficiently infect macrophages, and the pleiotropic effects of macrophage-tropism including the ability to infect cells lacking CD4 and increased neutralization sensitivity. Questions remain about the relationship between rates of macrophage infection and viral pathogenesis, with some evidence suggesting that elevated levels of macrophage infection may contribute to greater pathogenesis in non-natural SIV hosts. Alternatively, extensive infection of macrophages may only emerge in the context of high viral loads and immunodeficiency, making it a symptom of highly pathogenic infections, not a primary driver of pathogenesis.

摘要

大多数髓系细胞表达受体和辅助受体,使它们易受灵长类慢病毒(SIV 和 HIV)感染。然而,巨噬细胞是唯一普遍被 SIV 和/或 HIV 感染的髓系细胞。受感染的巨噬细胞的频率在特定的宿主和病毒组合以及疾病状态下有很大的差异,在非天然宿主(即亚洲非人灵长类动物(亚洲 NHPs))的致病性 SIV 感染和未经治疗的 HIV-1 感染的晚期,感染率最高。相比之下,由于进入和/或进入后限制机制,来自天然 SIV 宿主(即非洲 NHPs)的巨噬细胞基本上不受感染。这些巨噬细胞感染率的高度可变可能源于宿主免疫环境、进入和进入后限制机制、病毒适应有效感染巨噬细胞的能力以及巨噬细胞嗜性的多效性效应(包括感染缺乏 CD4 的细胞和增加中和敏感性的能力)的差异。关于巨噬细胞感染率与病毒发病机制之间的关系仍存在疑问,一些证据表明,巨噬细胞感染水平的升高可能导致非天然 SIV 宿主的发病机制更大。或者,巨噬细胞的广泛感染可能仅在高病毒载量和免疫缺陷的情况下出现,使其成为高度致病性感染的症状,而不是发病机制的主要驱动因素。